Short-Term CPAP Improves Biventricular Function in Patients with Moderate-Severe OSA and Cardiometabolic
Ioana Mădălina Zota1, Radu Andy Sascău1, Cristian Stătescu1
1Department of Medical Specialties (I), Faculty of Medicine, Grigore T. Popa-University of Medicine and Pharmacy, 700115 Iasi, Romania.
Continuous positive airway pressure (CPAP) therapy significantly improves biventricular function in patients with obstructive sleep apnea (OSA) and cardiometabolic conditions. Adherence to short-term CPAP enhances cardiac strain and function, particularly left ventricular global longitudinal strain.
Area of Science:
- Cardiology
- Sleep Medicine
- Cardiovascular Imaging
Background:
- Obstructive sleep apnea (OSA) is a prevalent sleep-disordered breathing condition linked to cardiovascular complications.
- Continuous positive airway pressure (CPAP) is the primary treatment for moderate-severe OSA, yet patient adherence remains a challenge.
- Patients with OSA often present with cardiometabolic comorbidities like hypertension, obesity, and diabetes.
Purpose of the Study:
- To evaluate the short-term effects of CPAP on biventricular function in patients with moderate-severe OSA and cardiometabolic comorbidities.
- To assess changes in echocardiographic parameters after 8 weeks of CPAP therapy.
- To identify sensitive markers of CPAP-induced cardiac changes.
Main Methods:
- Prospective study of 57 newly diagnosed moderate-severe OSA patients before CPAP initiation.
- Clinical examination, ambulatory blood pressure monitoring, and comprehensive echocardiography at baseline and after 8 weeks of CPAP.
- Analysis of biventricular function parameters, including left ventricular global longitudinal strain (LV-GLS) and right ventricular (RV) parameters.
Main Results:
- Short-term CPAP therapy led to significant improvements in left ventricular global longitudinal strain (LV-GLS).
- CPAP also improved isovolumetric relaxation time, transmitral E/A ratio, and several right ventricular parameters (RV diameter, RV wall thickness, RV S', TAPSE).
- LV-GLS emerged as a more sensitive indicator of CPAP-related changes in left ventricular systolic function than LVEF.
Conclusions:
- Short-term CPAP therapy positively impacts biventricular function in patients with moderate-severe OSA and cardiometabolic comorbidities.
- The observed cardiac benefits are contingent upon patient adherence to CPAP treatment.
- LV-GLS is a valuable and sensitive echocardiographic marker for assessing CPAP's therapeutic effects on cardiac function.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Sleep Apnea
The condition is more prevalent among...
COPD: Management Using Bronchodilators and Corticosteroids
Cardiomyopathy V: Interprofessional Care


